Pathstone Holdings’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Pathstone Holdings's AMGN Position: Q2 2026 in Review
Pathstone Holdings increased its Amgen (AMGN) stake by 4.1% in Q2 2026, buying an estimated $1.28M and bringing the position to 96,026 shares worth $34.8M. The position accounts for 0.1% of the portfolio, ranked #143.
Pathstone Holdings first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Pathstone Holdings held 96,026 shares of Amgen worth $34.8M as of Q2 2026.
- Pathstone Holdings bought 3,738 Amgen shares in Q2 2026, an estimated $1.28M.
- Amgen made up 0.1% of Pathstone Holdings's portfolio in Q2 2026, its #143 holding.
- Pathstone Holdings first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.